These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12151172)

  • 1. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.
    Peterson GM
    Obstet Gynecol; 2002 Aug; 100(2):381; author reply 381-2. PubMed ID: 12151172
    [No Abstract]   [Full Text] [Related]  

  • 2. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.
    Soller RW
    Obstet Gynecol; 2002 Aug; 100(2):380-1. PubMed ID: 12151171
    [No Abstract]   [Full Text] [Related]  

  • 3. Vulvo-vaginal candidiasis.
    Medlen L
    Nurs RSA; 1987; 2(11-12):35. PubMed ID: 3444468
    [No Abstract]   [Full Text] [Related]  

  • 4. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.
    Ferris DG; Nyirjesy P; Sobel JD; Soper D; Pavletic A; Litaker MS
    Obstet Gynecol; 2002 Mar; 99(3):419-25. PubMed ID: 11864668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis.
    Guaschino S; De Seta F; Sartore A; Ricci G; De Santo D; Piccoli M; Alberico S
    Am J Obstet Gynecol; 2001 Mar; 184(4):598-602. PubMed ID: 11262459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems with over-the-counter vaginal preparations.
    Kabongo ML
    Am Fam Physician; 1993 Sep; 48(4):579. PubMed ID: 8379485
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution to the therapy of vulvuovaginal mycoses (author's transl)].
    Wenzel-Heiniger K
    Schweiz Rundsch Med Prax; 1976 Mar; 65(10):287-8. PubMed ID: 1257188
    [No Abstract]   [Full Text] [Related]  

  • 8. The development of evidence-based guidelines for over-the-counter treatment of vulvovaginal candidiasis.
    Bond CM; Watson MC;
    Pharm World Sci; 2003 Aug; 25(4):177-81. PubMed ID: 12964498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal vaginal discharge: what does and does not work in treating underlying causes.
    French L; Horton J; Matousek M
    J Fam Pract; 2004 Nov; 53(11):890-4. PubMed ID: 15527726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Summary of the national seminar on diagnosis and treatment of female vulvar-vaginal diseases].
    Jiang L; Wang JL; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):483-5. PubMed ID: 19080507
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic principles in vulvovaginal dermatology.
    Beecker J
    Dermatol Clin; 2010 Oct; 28(4):639-48. PubMed ID: 20883909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in prescribing for vulvovaginal candidiasis in the United States.
    McCaig LF; McNeil MM
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):113-20. PubMed ID: 15386715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gynecologists warn against over-the-counter antifungal agents. Uncontrolled use can worsen vulvovaginal problems].
    Rylander E; Strand A
    Lakartidningen; 1998 Jan; 95(3):134-5. PubMed ID: 9467277
    [No Abstract]   [Full Text] [Related]  

  • 14. Improving appropriate use of antifungal medications: the role of an over-the-counter vaginal pH self-test device.
    Roy S; Caillouette JC; Faden JS; Roy T; Ramos DE
    Infect Dis Obstet Gynecol; 2003; 11(4):209-16. PubMed ID: 15108867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of erosive vulvovaginal lichen planus with methotrexate.
    Jang N; Fischer G
    Australas J Dermatol; 2008 Nov; 49(4):216-9. PubMed ID: 18855784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulvovaginal lichen planus treatment: a survey of current practices.
    Cooper SM; Haefner HK; Abrahams-Gessel S; Margesson LJ
    Arch Dermatol; 2008 Nov; 144(11):1520-1. PubMed ID: 19015433
    [No Abstract]   [Full Text] [Related]  

  • 17. Depo-Provera in the treatment of recurrent vulvovaginal candidiasis.
    Dennerstein GJ
    J Reprod Med; 1986 Sep; 31(9):801-3. PubMed ID: 2945926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns.
    Sihvo S; Ahonen R; Mikander H; Hemminki E
    Fam Pract; 2000 Apr; 17(2):145-9. PubMed ID: 10758077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s.
    Mårdh PA; Wågström J; Landgren M; Holmén J
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):99-108. PubMed ID: 15739824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerance of local treatment of acute vulvovaginal candidiasis with 4 different single doses (10, 25, 50 and 100 mg) of Ro 14-4767 versus a 7-day treatment with miconazole.
    Hubert T; Van Bulck B; Van Waes A; Van de Velde E; Van der Pas H; Lambin A
    J Chemother; 1989 Jul; 1(4 Suppl):933-5. PubMed ID: 16312711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.